New lipid guidelines are out!!! 2026 ACC/AHA Guideline on the Management of Dyslipidemia www.ahajournals.org/doi/10.1161/...

Excellent overview in The Washington Post on the systemic impact of sustained hypertension — from LVH to CKD and cognitive decline. Kudos to Drs. @drwanpen.bsky.social , John B, and @jordybc.bsky.social for evidence base insight. 🔗 www.washingtonpost.com/wellness/202... #Hypertension #Cardiology

🧠 Dr. Vaidya’s @anandvaidya17.bsky.social practical approach to primary aldo, distilled into one clean, clinic-ready infographic: This is high-yield, no-fluff, practice-changing stuff.

Really interesting case!

🚨 Fresh Hypertension Guidelines Alert 🚨 Don’t get caught treating high blood pressure like it’s 2024 👀 
In Episode #509, West Philly doc Dr. Jordy Cohen @jordybc.bsky.social keeps our hypertension management fresh with a clear walk-through of the new HTN guidelines & more! www.thecurbsiders.com

Dan Batlle & I wrote about testing for primary aldosteronism, bringing a critical lens to the usual approach www.ahajournals.org/doi/full/10....

⏳In 7 days an impt discussion on #BloodPressure across Womens #Lifespan coordinated by #NIH #NHLBI There is still time to register👉🏻 web.cvent.com/event/e7c2bdc3… Looking fwd to presenting & learning! Hope you will joi#CardioSkyk#MedSkyky

Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN. med.stanford.edu/nephrology/e...

The new ⌚️ will have hypertensive notifications This doesn’t seem like a cuffless BP - but more like a notification ‘you may have hypertension, go check your BP’ ? From www.apple.com/newsroom/202... @jordybc.bsky.social @drwanpen.bsky.social @spjuraschek.bsky.social @daichishimbo.bsky.social?

Beta blockers remain overused for #hypertension in the VA (though the tens line is going down, very slowly) jamanetwork.com/journals/jam... in @jama.com from @jordybc.bsky.social et al OTOH: I think ESRD should count as a somewhat compelling indication? Almost all HD pts here are on bisoprolol

Commentary on expanded screening for primary aldosteronism in the new HTN guideline. www.ahajournals.org/doi/10.1161/... 🔓

If you want fresh, live discussion on the new guidelines, join us in Baltimore this September! Writers will present their rationales and future directions! Hypertension 2025 Scientific Sessions - Professional Heart Daily | American Heart Association share.google/WD0vuS8NuHnF...

New AHA Hypertension guidelines are out! professional.heart.org/en/science-n...

2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults 08/28/25 @ 12:00 pm – 1:30 pm CDT Featuring writing committee members and highlights from the ACC/AHA Committee on Clinical Practice Guidelines targetbp.org/event/target...

A bold guideline from the beginning! “We suggest that all individuals with hypertension be screened for primary aldosteronism”

Balancing the risk for clotting and bleeding is constant challenge for cardiologists, so I was very excited to see in this month’s #JACCBTS work on targeting different parts of the coagulation cascade (Factor 11, FXI) to reduce bleeding risk while lowering risk for thrombosis. 🧵: 1/8

New PA Endo guideline is also out by experts @anandvaidya17.bsky.social #Cardiosky @hswapnil.medsky.social doi.org/10.1210/clin...

We have an unexpected late opening in our vascular medicine 1 year fellowship program for 2025-2026 @harringtonhvi.bsky.social Outstanding clinical training with multi specialty faculty in a highly collaborative environment. Chat if interested and please help spread the word. #CardioSky

In this month’s issue of #JACCBTS, Jønck, et al. explore the effects of cytokine inhibitors on cardiovascular adaptability in rheumatoid arthritis (RA). Read below to see what they found! 🧵 1/9 @jaccjournals.bsky.social

It's World Hypertension Day #nephsky #medsky mailchi.mp/whleague.org...

There you have it: BEDMED published in @jama.com jamanetwork.com/journals/jam... h/t @drjmluther.bsky.social No difference in bedtime versus morning BP meds - as expected #NephSky #Hypertension 1/

Also read the accompanying editorial from @jordybc.bsky.social www.acpjournals.org/doi/10.7326/... Don’t let the complexity of traditional PA screening and confirming diagnosis stop you - just measure renin to start and go from there

I’ll always remember the first congestive hepatopathy patient I took care of as an intern @vumc.bsky.social. The pathology was so different from anything else, so when I saw an article on this in this month’s #JACCBTS I couldn’t wait to learn more about it. (🧵: 1/10) @jaccjournals.bsky.social

Follow @michaelraddatz.bsky.social @jeffhsumd.bsky.social and @vascularimmuno.bsky.social and I for more updates on great science from #JACCBTS (🧵: 10/10)

The ASIs have arrived www.nejm.org/doi/full/10.... Aldosterone synthase inhibitors - first one to finish the phase 3 line #Lorundrostat #Hypertension

Register now! site.pheedloop.com/event/HCVirt...

Interesting case report: an unusual (and new to me) etiology of AME. academic.oup.com/jcemcr/artic... #nephsky

Great pearls by @jbrianbyrd.bsky.social in evaluating pts for RDN at #ACC25: 1. confirm uncontrolled HTN with out of office measure (Amb BP monitor); 2. trial spironolactone 1st; 3. shared decision making key - care team should include HTN specialists beyond those performing the procedure #cardiosky

Excited to see this review on GWAS in hypertension out in print with @endocelldoc.bsky.social and Todd Edwards. www.ahajournals.org/doi/full/10....

❤️🏥🎙️ #474 Resistant Hypertension the Next Frontier! Treat Hypertension Like No Doctor Has Ever Treated Hypertension Before! @jordybc.bsky.social Treating hypertension never gets boring. Learn about emerging therapies and how to continue to tackle this common diagnosis like a pro.

Key slide @ahascience.bsky.social #EpiLifestyle25

Ever get back a genetic report and dread seeing the words “Variant of Unknown Significance (VUS)”😱? The # of VUSs are escalating as more patients get sequenced – join me in learning about how @spfisterer.bsky.social and colleagues are helping tackle the VUS problem 🧬 in this month's #JACCBTS🧵:1/9

By @katherinejwu.com "The NIH... supported 99 percent of the drugs approved in the U.S. from 2010 to 2019. The agency has had a hand in “nearly all of our major medical breakthroughs over the past several decades,” The NIH is in a struggle for its (and our) lives. This is existential to America:

Disease diagnostics using machine learning of B cell and T cell receptor sequences www.science.org/doi/10.1126/... TL;DR: BCRs ARE ALL YOU NEED! (Well actually .... keep reading) 1/

In this month’s issue of #JACCBTS, Brambilla, et al. explore the role of platelet function in long COVID. Read below ⬇️ to see what they found! 🧵 1/n @jeffhsumd.bsky.social @jaccjournals.bsky.social @vascularimmuno.bsky.social @jeanwassenaar.bsky.social

Our recent review on immune cells in the development of hypertension and renal injury is now In Press at AJP-Renal! journals.physiology.org/doi/abs/10.1...

Interesting interactive case presentation on an under-recognized cause of hypertension. @anandvaidya17.bsky.social @nejm.org www.nejm.org/doi/10.1056/...

Enjoyed writing this editorial with Jessica Faulkner on a really interesting paper by Maria Pabon and @mchonig.bsky.social on a role for METAP1 in preeclampsia. www.ahajournals.org/doi/10.1161/...

In our latest led by Maria Pabon (MGB/BWH) now in Circ Res, we sequenced RNA from venous endothelial cells from 🤰 w/ or w/o preeclampsia We 👀 evidence that an aminopeptidase, METAP1, drives EC dysfunction in preeclampsia www.ahajournals.org/doi/10.1161/... #CardioObstetrics @mghcvrc.bsky.social